GL1X · GenesisL1 explorer

MolNFT v1 · #58821 · protein

Crystal structure of escherichia COLI signal peptide peptidase (sppa), native crystals

3BF0 · Protease 4: “Crystal structure of escherichia COLI signal peptide peptidase (sppa), native crystals”. X-ray diffraction, 16 pockets (best druggability 0.78). MolNFT v1 #58821 on GenesisL1: 3D structure, binding sites and pockets in…

PDB
3BF0
Type
protein
Length
1,902 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease 4
EC
3.4.21.-
UniProt
P08395
Pockets
16 · best druggability 0.78

Structure

x-ray diffraction · 4 distinct chains · 42% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtease 4 (EC 3.4.21.-)protein47442% helix, 25% strandP08395
BProtease 4 (EC 3.4.21.-)protein47441% helix, 24% strandP08395
CProtease 4 (EC 3.4.21.-)protein47842% helix, 24% strandP08395
DProtease 4 (EC 3.4.21.-)protein47642% helix, 24% strandP08395

Pockets

16 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110020.780.80109empty
28880.770.8087empty
39990.770.7989empty
47300.710.7876empty
55200.700.7946empty

Interfaces

4 interfaces between chains.

  • B–D · 1587 Ų buried · 27 hydrogen bonds · protein-protein
  • A–C · 1542 Ų buried · 27 hydrogen bonds · protein-protein
  • C–D · 1510 Ų buried · 23 hydrogen bonds · protein-protein
  • A–B · 1457 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 3BF0 · Crystal structure of Escherichia coli Signal peptide peptidase (SppA), Native crystals · the same entry in another collection · chain D against D, TM-score 1.00
  • P08395 · AlphaFold monomer V2.0 prediction for protease 4 (P08395) · a predicted model of the same protein · chain B against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.